Heron Therapeutics
HRTX
#7401
Rank
C$0.48 B
Marketcap
$3.20
Share price
-3.25%
Change (1 day)
-14.06%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.58

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.67. In 2022 the company made an earnings per share (EPS) of -$2.48 an increase over its 2021 EPS that were of -$3.22.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.58-36.23%
2022-$2.48-23.11%
2021-$3.22-10%
2020-$3.58-0%
2019-$3.581.21%
2018-$3.54-32.7%
2017-$5.25-19.34%
2016-$6.5154.76%
2015-$4.211.73%
2014-$4.14-16.23%
2013-$4.9491.67%
2012-$2.58-31.45%
2011-$3.76-27.06%
2010-$5.15-43.75%
2009-$9.16-57.33%
2008-$21.47-82.92%
2007-$125.6820.61%
2006-$104.20175.76%
2005-$37.79-21.43%
2004-$48.09100%
2003-$24.05-38.24%
2002-$38.93161.54%
2001-$14.89-106.46%
2000$230.302051.55%
1999$10.70839.73%
1998$1.14-105.48%
1997-$20.80-88.16%
1996-$175.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.86-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.20-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.33 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.25-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.36 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA